-+ 0.00%
-+ 0.00%
-+ 0.00%

MIRUM PHARMA EXEC SAYS BRELOVITUG’S MAIN PATENT RUNS UNTIL 2041, COULD BE EXTENDED FURTHER

Reuters·12/08/2025 13:40:56

Please log in to view news